Anxiolytic Effects of Socio-aesthetics in Cancer Patients Undergoing Chemotherapy
Anxiolytic Effects of Socio-aesthetics in Cancer Patients Undergoing Chemotherapy (PASITHEA)
GCS Ramsay Santé pour l'Enseignement et la Recherche
192 participants
Mar 23, 2023
INTERVENTIONAL
Conditions
Summary
The purpose of the study is to assess the average of the "State Anxiety" score of the State Trait Inventory Anxiety at the end of the third cycle of chemotherapy compared to the pre-treatment score (inclusion)
Eligibility
Inclusion Criteria4
- Patient with cancer treated with adjuvant chemotherapy with an interval of 14 or 21 days for the first 3 cycles;
- Chemotherapy naïve patient;
- Patient speaking and understanding French and able to complete the questionnaires;
- Patient having been informed and having signed an informed consent form to participate in the study.
Exclusion Criteria6
- Patient who has already benefited from socio-aesthetic care;
- Protected patient (under legal protection, or deprived of liberty by judicial or administrative decision);
- Patient unable to understand the information related to the study (linguistic, psychological, cognitive reasons, etc.);
- Pregnant or likely to be pregnant (of childbearing age, without effective contraception) or breastfeeding;
- Patient participating in another clinical trial, or in a period of exclusion from another clinical trial;
- Patient not benefiting from a social security scheme.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Group A (Socio-aesthetic care): 3 sessions carried out by a socio-esthetician, during the first administration of chemotherapy.
Group B (control) will not benefit of socio-aesthetic care during chemotherapy but will benefit all existing support care in the center and accessible to patients: psychology consultation, sophrology, art therapy, physiotherapy, hypnosis. The patient will receive support care (maximum 2) during the intercure.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05649852